tiprankstipranks
Kuala Lumpur Kepong Bhd. (KLKBF)
OTHER OTC:KLKBF
US Market
Holding KLKBF?
Track your performance easily

Kuala Lumpur Kepong Bhd (KLKBF) Income Statement

7 Followers

Kuala Lumpur Kepong Bhd Income Statement

Last quarter (Q1 2023), Kuala Lumpur Kepong Bhd's total revenue was $6.71B, a decrease of -1.77% from the same quarter last year. In Q1, Kuala Lumpur Kepong Bhd's net income was $443.04M. See Kuala Lumpur Kepong Bhd’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 22Sep 21Sep 20Sep 19Sep 18
Total Revenue
$ 20.05B$ 27.15B$ 19.92B$ 15.45B$ 15.44B$ 18.28B
Cost of Revenue
-$ 22.17B$ 16.49B$ 13.53B$ 13.86B$ 16.21B
Gross Profit
-$ 4.97B$ 3.42B$ 1.92B$ 1.58B$ 2.07B
Operating Expense
$ 17.68B$ 1.59B$ 528.27M$ 652.15M$ 694.49M$ 1.00B
Operating Income
$ 2.37B$ 3.38B$ 2.89B$ 1.42B$ 886.78M$ 1.06B
Net Non Operating Interest Income Expense
$ -277.03M$ -358.13M$ -237.71M$ -127.75M$ -97.88M$ -94.69M
Other Income Expense
------
Pretax Income
$ 2.13B$ 3.22B$ 2.98B$ 1.19B$ 823.93M$ 988.79M
Tax Provision
$ 426.84M$ 781.12M$ 524.37M$ 328.68M$ 173.19M$ 328.47M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 1.55B$ 2.17B$ 2.26B$ 772.60M$ 617.50M$ 609.37M
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----$ 69.32M$ 69.22M
Total Expenses
$ 17.68B$ 23.77B$ 17.02B$ 14.18B$ 14.55B$ 17.22B
Net Income From Continuing And Discontinued Operation
$ 1.55B$ 2.17B$ 2.26B$ 772.60M$ 617.50M$ 609.37M
Normalized Income
$ 1.53B$ 2.16B$ 2.26B$ 782.20M$ 617.50M$ 609.37M
Interest Expense
$ 277.03M$ 124.17M$ 47.08M$ 14.20M$ 14.36M$ 61.31M
EBIT
$ 2.41B$ 3.34B$ 3.02B$ 1.20B$ 838.28M$ 1.05B
EBITDA
$ 3.12B$ 4.27B$ 3.66B$ 1.82B$ 1.44B$ 1.58B
Currency in USD

Kuala Lumpur Kepong Bhd Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis